Cancer Immunotherapy

Why choose this course?

• You'll be taught by our expert staff and innovative speakers from the biopharmaceutical industry
• Our modern Science Building provides excellent facilities for laboratory experiments, including DNA and genomic analysis eg QPCR, protein and proteomic science (eg MALDI-ToF), cell culture and Enzyme-based assays, isolated tissue studies and immunohistochemistry
• When you graduate, you'll be equipped to work in a broad range of fields including medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law
• We adopt a blended learning approach to teaching, focussing on problem-based scenarios so you can develop strong critical analysis skills. You'll benefit from exposure to practical techniques and guaranteed laboratory-based research projects.

What will I study?

You'll benefit from the research interests of the Bioscience Research Group. These include studies of the tumour microenvironment and communication with infiltrating immune cells, the methods tumours employ to diminish the effectivity of immune effector mechanisms and how tumours communicate using extracellular vesicles with pre-metastatic sites. We'll cover topics such as adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade.

Teaching will be delivered through lectures, tutorials and practical classes. You'll immerse yourself in a research project which utilises problem-based and self-directed learning. You'll explore case studies to gain a strong critical understanding. Through your research projects, carried out in our innovative Science Building and supervised by world-leading researchers, you'll be trained in data collection, analysis and its interpretation. You'll also benefit from expert external speakers from the biopharmaceutical industry.

About the course

The aim of the MSc in Cancer Immunotherapy is through an understanding of the numerous ways in which cancers and the immune system interact, to learn how cancer immunotherapies are developed. The utilisation of the immune system in cancer therapy has been a long standing goal in the field. The course will provide a thorough understanding of immune effector mechanisms and of cancer biology and the personal skills the students will develop, through problem-based learning and self-directed learning.

Alternatively, consider taking our other MSc Cancer Immunotherapy routes:

• MSc Cancer Immunotherapy with Placement Year
• MSc Cancer Immunotherapy with Advanced Research

Completion of a four year bachelors degree with GPA 2.4 or above.

What job can I get?

In cancer immunology a long-term goal has been the activation of immune effector mechanisms for therapy. You will acquire skills needed for careers in the exponentially growing cancer immunotherapy industries (Roche, Merck, Astra Zeneca and Small Medium Sized Enterprises). Graduates of the MSc Cancer Immunotherapy may go on to work in a broad range of fields including: medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing/science journalism, education, or patent law. Alternatively, you may also use the MSc Cancer Immunotherapy degree to underpin an application to study for a research degree such as MRes, MSc by Research, or a PhD in a related field.

Download the direct application form (PDF - 0.19 Mb)

Please note: You must download the application form to your computer before you complete it. If you complete the form in the browser window, the information you have entered may be lost when the form is saved.

When you have completed your pdf application form, please send it to:

admppc@herts.ac.uk

Complex Admissions
University of Hertfordshire
Hatfield
Hertfordshire
AL10 9AB
UK